Evidence map›Paper›PMID 42313180›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2026

Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis Foundation.

Manju Chandran, Athanasios D Anastasilakis, Robert D Blank, Neil Binkley, Thierry Chevalley, M Kassim Javaid, Willem F Lems, E Michael Lewiecki, Polyzois Makras, Julien Paccou and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Manju ChandranOsteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.ORCID http://orcid.org/0000-0001-9119-8443
Athanasios D AnastasilakisDepartment of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece.
Robert D BlankGarvan Institute of Medical Research, Darlinghurst, Australia.
Neil BinkleyOsteoporosis Clinical Research Program, University of Wisconsin, Madison, WI, USA.
Thierry ChevalleyService of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
M Kassim JavaidNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Willem F LemsDepartment of Rheumatology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
E Michael LewieckiNew Mexico Clinical Research & Osteoporosis Center Albuquerque, Albuquerque, NM, USA.
Polyzois MakrasDepartment of Endocrinology and Diabetes and Department of Medical Research, 251 Hellenic Air Force & VA General Hospital, Athens, Greece.
Julien PaccouDepartment of Rheumatology, University Lille, CHU Lille, MABlab ULR 4490, Lille, France.
Stuart SilvermanCedars Sinai Medical Center, Los Angeles, CA, USA.
Thierry ThomasService de Rhumatologie, Centre Hospitalo-Universitaire de Saint-Étienne, INSERM 1059, Université Jean Monnet, Saint-Etienne, France.
Maria Luisa BrandiFIRMO Foundation, Florence, Italy and McMaster University, Hamilton, Canada.
Eugene McCloskeyMellanby Centre for Musculoskeletal Research, Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.
Etienne CavalierDepartment of Clinical Chemistry, CIRM, University of Liege, Liege, Belgium.
Kristina E ÅkessonClinical and Molecular Osteoporosis Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.
Gerold HolzerDepartment of Orthopaedic Surgery, Medical University of Vienna, Vienna, Austria. gerold.holzer@meduniwien.ac.at.
Fracture Working Group of the Committee of Scientific Advisors (CSA) of the IOF

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This expert position statement reframes arthroplasty and spinal fusion complications under the unified endpoint of implant fixation failure, defined as loss of mechanical integrity of the bone-implant unit over time. It synthesizes mechanistic and clinical evidence and provides evidence-informed recommendations for peri-operative bone health optimization.

backgroundOsteoporosis is traditionally conceptualized as causing fragility fractures. However, compromised bone quality also affects the integrity of bone-implant constructs, influencing whether implants maintain fixation, interfaces remain stable, and fusion constructs consolidate.

objectiveTo synthesize mechanistic, translational, and clinical evidence on how osteoporosis and osteoporosis pharmacotherapies influence implant fixation failure across arthroplasty and spinal fusion, and to provide evidence-informed clinical recommendations for peri-operative bone health assessment and optimization within a unified construct-level framework.

methodsA position statement was developed following a structured literature search. Evidence was synthesized narratively by defining implant fixation failure as a construct-level outcome encompassing periprosthetic fracture, loosening, subsidence, pseudarthrosis, and junctional failure. Recommendations were categorized by strength (strong or conditional) and certainty of evidence (high, moderate, or low).

resultsLow bone mineral density (BMD) is associated with implant fixation failure across arthroplasty and spinal fusion. In arthroplasty, randomized trials demonstrate preservation of periprosthetic BMD with bisphosphonates, while registry analyses suggest improved implant survival. In spinal fusion, antiresorptive and anabolic therapies influence fixation-related parameters, with anabolic agents showing the most consistent evidence for enhanced fusion mass and earlier union. Much of the literature relies on radiographic or biomechanical endpoints rather than definitive outcomes.

conclusionsViewing arthroplasty and spinal fusion complications through a shared construct-level perspective provides a coherent link between osteoporosis and reconstructive durability. Systematic peri-operative bone health optimization may improve construct longevity, although more definitive outcome-driven trials are needed. Closer integration between orthopedic surgeons and osteoporosis specialists will be central to advancing peri-operative bone health care.

Indexed as

arthroplastycage subsidenceimplant looseningosteoporosisperiprosthetic fracturepseudoarthrosis, osteoporosis treatmentscrew fixationspinal fusion

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.